Cognition Clinical Trial
Official title:
Higher Tea Consumption is Associated With Better Performance on Measures of Attention and Psychomotor Speed in the Very Old: The Newcastle 85+ Study
Verified date | September 2017 |
Source | Newcastle University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Studies have found a beneficial effect of tea consumption on the reduction of risk of
cognitive impairment and dementia in older aged populations. However, there is a paucity of
data on these associations in the very old defined as individuals aged 85 years and over.
Therefore, we hypothesized that higher tea consumption was associated with better global and
domain-specific cognitive function. We investigated the relationship between tea consumption
in the very old and measures of global cognitive function, memory, attention and psychomotor
speed.
The Newcastle 85+ Study was a longitudinal (5-years), population-based cohort study of
individuals aged 85+ years in North East England, United Kingdom. The final sample included
676 community-dwelling and institutionalized men and women recruited through general medical
practices.
Baseline tea consumption was assessed through a 2x24-hr multiple pass recall and longitudinal
measures of global and domain specific (memory, speed and attention) cognitive function
through the standardized mini-mental state examination and the cognitive drug research
system. Linear mixed models, controlling for demographic (e.g. age, sex and education) and
health variables were used to determine whether tea consumption was protective against
cognitive decline.
Status | Completed |
Enrollment | 1042 |
Est. completion date | March 2013 |
Est. primary completion date | March 2013 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 85 Years to 85 Years |
Eligibility |
Inclusion Criteria: - Born in 1921 - Permanently registered with a participating general practice in Newcastle upon Tyne or North Tyneside primary care trusts in the UK Exclusion Criteria: - End-stage illness - Individuals who might pose a safety risk to a nurse visiting alone, with dementia - Clinical diagnosis of dementia at baseline |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Newcastle University | Newcastle upon Tyne |
Lead Sponsor | Collaborator |
---|---|
Newcastle University |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Standardized mini-mental state examination | Measure of global cognition (Score 0-30) | Baseline | |
Primary | Rate of decline of the standardized mini-mental state examination | Measure of global cognition (Score 0-30) | Baseline to 5 years follow-up | |
Secondary | Simple reaction time | Simple reaction time assessed using the Cognitive Drug Research (CDR) computerised system. The CDR tasks were presented on a hi-resolution Windows-based laptop computer (Motion Computing LE1600 Tablet PC with keyboard accessory) and participants responded using a two-button (NO/YES) response box. The participant is instructed to press "YES" as quickly as possible every time the word "YES" is presented on the screen. In total, 30 "YES" stimuli are presented with varying inter-stimulus interval. (ms) | Baseline | |
Secondary | Rate of reaction speed decline | Simple reaction time assessed using the Cognitive Drug Research (CDR) computerised system. The CDR tasks were presented on a hi-resolution Windows-based laptop computer (Motion Computing LE1600 Tablet PC with keyboard accessory) and participants responded using a two-button (NO/YES) response box.The participant is instructed to press "YES" as quickly as possible every time the word "YES" is presented on the screen. In total, 30 "YES" stimuli are presented with varying inter-stimulus interval. (ms) | Baseline to 3 years follow-up | |
Secondary | Choice reaction time | Choice reaction time assessed using the Cognitive Drug Research (CDR) computerised system. The CDR tasks were presented on a hi-resolution Windows-based laptop computer (Motion Computing LE1600 Tablet PC with keyboard accessory) and participants responded using a two-button (NO/YES) response box. Either the word "YES" or "NO" is presented on the screen and the participant is instructed to press the corresponding button as quickly as possible. There are 30 trials for each stimulus word, which is chosen randomly with equal probability, with varying inter-stimulus interval. (ms) | Baseline | |
Secondary | Rate of reaction choice decline | Choice reaction time assessed using the Cognitive Drug Research (CDR) computerised system. The CDR tasks were presented on a hi-resolution Windows-based laptop computer (Motion Computing LE1600 Tablet PC with keyboard accessory) and participants responded using a two-button (NO/YES) response box.Either the word "YES" or "NO" is presented on the screen and the participant is instructed to press the corresponding button as quickly as possible. There are 30 trials for each stimulus word, which is chosen randomly with equal probability, with varying inter-stimulus interval. (ms) | Baseline to 3 years follow-up | |
Secondary | Digit vigilance task | Digit vigilance task assessed using the Cognitive Drug Research (CDR) computerised system. The CDR tasks were presented on a hi-resolution Windows-based laptop computer (Motion Computing LE1600 Tablet PC with keyboard accessory) and participants responded using a two-button (NO/YES) response box. Target digit is randomly selected and constantly displayed to the right of the screen. A series of digits (0-9) are presented in the centre of the screen at the rate of 150 per minute. The participant is required to press the "YES" button as quickly as possible every time the digit in the series matches the target digit. There are 300 digits in the series and the task lasts for 2 minutes. (ms) | Baseline | |
Secondary | Rate of digit vigilance task decline | Digit vigilance task assessed using the Cognitive Drug Research (CDR) computerised system. The CDR tasks were presented on a hi-resolution Windows-based laptop computer (Motion Computing LE1600 Tablet PC with keyboard accessory) and participants responded using a two-button (NO/YES) response box. Target digit is randomly selected and constantly displayed to the right of the screen. A series of digits (0-9) are presented in the centre of the screen at the rate of 150 per minute. The participant is required to press the "YES" button as quickly as possible every time the digit in the series matches the target digit. There are 300 digits in the series and the task lasts for 2 minutes. (ms) | Baseline to 3 years follow-up | |
Secondary | Word recognition | Word recognition was assessed using the Cognitive Drug Research (CDR) computerised system. The CDR tasks were presented on a hi-resolution Windows-based laptop computer (Motion Computing LE1600 Tablet PC with keyboard accessory) and participants responded using a two-button (NO/YES) response box. A list of words is presented on screen for the subject to remember. Immediately after the presentation the subject is asked to recall as many words as possible. 20 minutes later, the same list of words is presented with added distracter words. For each word, the subject is asked to indicate whether or not it belongs o the original list by pressing 'YES' or 'NO'. | Baseline | |
Secondary | Rate of word recognition decline | Word recognition was assessed using the Cognitive Drug Research (CDR) computerised system. The CDR tasks were presented on a hi-resolution Windows-based laptop computer (Motion Computing LE1600 Tablet PC with keyboard accessory) and participants responded using a two-button (NO/YES) response box.A list of words is presented on screen for the subject to remember. Immediately after the presentation the subject is asked to recall as many words as possible. 20 minutes later, the same list of words is presented with added distracter words. For each word, the subject is asked to indicate whether or not it belongs to the original list by pressing 'YES' or 'NO'. | Baseline to 3 years follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT04540523 -
Home-Based Exergaming Intervention
|
N/A | |
Suspended |
NCT01212029 -
Testing and Calibration of Non-Invasive Optical Imaging Technology for Functional Brain Imaging
|
N/A | |
Enrolling by invitation |
NCT05273970 -
Electrochemical and Electrophysiological Study
|
N/A | |
Recruiting |
NCT05227352 -
Bio-Experiential Spaces for Mental Health in Healthworkers
|
N/A | |
Completed |
NCT02671149 -
The Effect of Small Changes in Hydration on Cognition
|
N/A | |
Completed |
NCT01333306 -
Enhancing Cognitive Training Using tDCS
|
Phase 1 | |
Recruiting |
NCT05542199 -
Nutrition for Brain and Body Health (BB-Health) Feasibility Trial
|
N/A | |
Recruiting |
NCT06254638 -
Effectiveness of a Multicomponent Intervention to Promote Physical Activity Levels During the School Day (MOVESCHOOL)
|
N/A | |
Recruiting |
NCT06331286 -
The Effect of Dulaglutide as an Adjuvant Therapy on Cognitive Function in Bipolar Disorder Patients With Obesity
|
N/A | |
Completed |
NCT05998096 -
A Randomized Study to Examine the Ability of a Caffeine-Based Energy Drink to Impact Energy Expenditure, Fat Oxidation, Reaction Time, and Other Perceptual Indicators
|
N/A | |
Withdrawn |
NCT03224559 -
Applying Neuromodulation to Accelerate Training Effects
|
||
Completed |
NCT03129048 -
Mediterranean Diet, Weight Loss, and Cognition in Obese Older Adults
|
N/A | |
Recruiting |
NCT05394363 -
Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents
|
||
Suspended |
NCT05107947 -
Light in Frail Elderly - the Effect of a Dynamic Light for Sleep and Circadian Rhythm
|
N/A | |
Recruiting |
NCT05372172 -
Tennessee Alzheimer's Project
|
||
Recruiting |
NCT05132517 -
Magnesium and Cognition After Stroke
|
||
Recruiting |
NCT05992571 -
Oral Ketone Monoester Supplementation and Resting-state Brain Connectivity
|
N/A | |
Recruiting |
NCT06097182 -
Postbiotic Intervention for Acute Stress Management
|
N/A | |
Completed |
NCT01223404 -
Nicotinic Modulation of the Default Network
|
N/A | |
Completed |
NCT00687102 -
Cognition in the Study of Tamoxifen and Raloxifene
|
Phase 3 |